BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 23481184)

  • 1. Accuracy of a nomogram for prediction of lymph-node metastasis detected with conventional histopathology and ultrastaging in endometrial cancer.
    Koskas M; Chereau E; Ballester M; Dubernard G; Lécuru F; Heitz D; Mathevet P; Marret H; Querleu D; Golfier F; Leblanc E; Luton D; Rouzier R; Daraï E
    Br J Cancer; 2013 Apr; 108(6):1267-72. PubMed ID: 23481184
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Can risk groups accurately predict non-sentinel lymph node metastasis in sentinel lymph node-positive endometrial cancer patients? A Turkish Gynecologic Oncology Group Study (TRSGO-SLN-004).
    Altin D; Taskin S; Tokgozoglu N; Vatansever D; Guler AH; Gungor M; Tasci T; Turan H; Kahramanoglu I; Yalcin I; Celik C; Kose F; Ortac F; Arvas M; Ayhan A; Taskiran C
    J Surg Oncol; 2021 Feb; 123(2):638-645. PubMed ID: 33259650
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The incidence and clinical significance of the micrometastases in the sentinel lymph nodes during surgical staging for early endometrial cancer.
    Ferraioli D; Chopin N; Beurrier F; Carrabin N; Buenerd A; Mathevet P
    Int J Gynecol Cancer; 2015 May; 25(4):673-80. PubMed ID: 25902281
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pathologic ultrastaging improves micrometastasis detection in sentinel lymph nodes during endometrial cancer staging.
    Kim CH; Soslow RA; Park KJ; Barber EL; Khoury-Collado F; Barlin JN; Sonoda Y; Hensley ML; Barakat RR; Abu-Rustum NR
    Int J Gynecol Cancer; 2013 Jun; 23(5):964-70. PubMed ID: 23694985
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of Metastatic Regional Lymph Node Locations and Predictors of Para-aortic Lymph Node Involvement in Endometrial Cancer Patients at Risk for Lymphatic Dissemination.
    Altay A; Toptas T; Dogan S; Simsek T; Pestereli E
    Int J Gynecol Cancer; 2015 May; 25(4):657-64. PubMed ID: 25647255
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Survival impact of lymphadenectomy stratified by nodal metastatic probability in endometrial cancer.
    Koskas M; Fournier M; Luton D; Darai E; Rouzier R
    Ann Surg Oncol; 2014 Jul; 21(7):2376-82. PubMed ID: 24590435
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The Impact of Sentinel Node-Mapping in Staging High-Risk Endometrial Cancer.
    Baiocchi G; Mantoan H; Kumagai LY; Gonçalves BT; Badiglian-Filho L; de Oliveira Menezes AN; Faloppa CC; De Brot L; da Costa AABA
    Ann Surg Oncol; 2017 Dec; 24(13):3981-3987. PubMed ID: 29058141
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of sentinel lymph node metastases in apparent early-stage endometrial cancer: a multicenter observational study.
    De Vitis LA; Fumagalli D; Schivardi G; Capasso I; Grcevich L; Multinu F; Cucinella G; Occhiali T; Betella I; Guillot BE; Pappalettera G; Shahi M; Fought AJ; McGree M; Reynolds E; Colombo N; Zanagnolo V; Aletti G; Langstraat C; Mariani A; Glaser G
    Int J Gynecol Cancer; 2024 May; 34(5):689-696. PubMed ID: 38514100
    [TBL] [Abstract][Full Text] [Related]  

  • 9. One-step nucleic acid amplification vs ultrastaging in the detection of sentinel lymph node metastasis in endometrial cancer patients.
    Kosťun J; Pešta M; Sláma J; Slunéčko R; Vlasák P; Bouda J; Novotný Z; Topolčan O; Kučera R; Kulda V; Houfková K; Berezovskiy D; Bartáková A; Presl J
    J Surg Oncol; 2019 Mar; 119(3):361-369. PubMed ID: 30508294
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Low-Volume Lymph Node Metastasis Discovered During Sentinel Lymph Node Mapping for Endometrial Carcinoma.
    St Clair CM; Eriksson AG; Ducie JA; Jewell EL; Alektiar KM; Hensley ML; Soslow RA; Abu-Rustum NR; Leitao MM
    Ann Surg Oncol; 2016 May; 23(5):1653-9. PubMed ID: 26714954
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognosis for endometrial cancer patients treated with systematic pelvic and para-aortic lymphadenectomy followed by platinum-based chemotherapy.
    Sueoka K; Umayahara K; Abe A; Usami T; Yamamoto A; Nomura H; Matoda M; Okamoto S; Omatsu K; Kondo E; Kato K; Takeshima N
    Int J Gynecol Cancer; 2015 Jan; 25(1):81-6. PubMed ID: 25347094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of the sentinel node procedure to stage endometrial cancer.
    Ballester M; Dubernard G; Rouzier R; Barranger E; Darai E
    Ann Surg Oncol; 2008 May; 15(5):1523-9. PubMed ID: 18322758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prospective clinical trial of robotic sentinel lymph node assessment with isosulfane blue (ISB) and indocyanine green (ICG) in endometrial cancer and the impact of ultrastaging (NCT01818739).
    Backes FJ; Cohen D; Salani R; Cohn DE; O'Malley DM; Fanning E; Suarez AA; Fowler JM
    Gynecol Oncol; 2019 Jun; 153(3):496-499. PubMed ID: 31230614
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct Comparison of Logistic Regression and Recursive Partitioning to Predict Lymph Node Metastasis in Endometrial Cancer.
    Koskas M; Luton D; Graesslin O; Barranger E; Clavel-Chapelon F; Haddad B; Darai E; Rouzier R
    Int J Gynecol Cancer; 2015 Jul; 25(6):1037-43. PubMed ID: 25950129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Patterns of recurrence in endometrial cancer patients at risk of lymph node metastasis or recurrence according to extent of lymphadenectomy.
    Kim HJ; Kim TJ; Song T; Kim MK; Lee YY; Choi CH; Lee JW; Bae DS; Kim BG
    Int J Gynecol Cancer; 2012 May; 22(4):611-6. PubMed ID: 22398712
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of lymphovascular space invasion on a nomogram for predicting lymph node metastasis in endometrial cancer.
    Koskas M; Bassot K; Graesslin O; Aristizabal P; Barranger E; Clavel-Chapelon F; Haddad B; Luton D; Darai E; Rouzier R
    Gynecol Oncol; 2013 May; 129(2):292-7. PubMed ID: 23480871
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Validation of online calculators to predict the non-sentinel lymph node status in sentinel lymph node-positive breast cancer patients.
    Tanaka S; Sato N; Fujioka H; Takahashi Y; Kimura K; Iwamoto M
    Surg Today; 2013 Feb; 43(2):163-70. PubMed ID: 22722328
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection rate and diagnostic accuracy of sentinel-node biopsy in early stage endometrial cancer: a prospective multicentre study (SENTI-ENDO).
    Ballester M; Dubernard G; Lécuru F; Heitz D; Mathevet P; Marret H; Querleu D; Golfier F; Leblanc E; Rouzier R; Daraï E
    Lancet Oncol; 2011 May; 12(5):469-76. PubMed ID: 21489874
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Validation of a breast cancer nomogram for predicting nonsentinel node metastases after minimal sentinel node involvement: validation of the Helsinki breast nomogram.
    Ouldamer L; Arbion F; Balagny A; Fourquet F; Marret H; Body G
    Breast; 2013 Oct; 22(5):787-92. PubMed ID: 23473772
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of the sentinel lymph node algorithm with blue dye labeling for early-stage endometrial cancer in a multicentric setting.
    Vidal F; Leguevaque P; Motton S; Delotte J; Ferron G; Querleu D; Rafii A
    Int J Gynecol Cancer; 2013 Sep; 23(7):1237-43. PubMed ID: 23839245
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.